Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial

Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera · 2026

Read Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial by Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13141164.txt.

Description

Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, and Emmanuel Carrera set out a 2026 trial protocol for a drug to aid stroke recovery. No drug yet helps patients regain function past the acute phase. The drug, maraviroc, blocks a receptor whose block freed brain rewiring in animal work.

Eighty patients with mid-level arm weakness will join within a week of their stroke. Half get the drug twice a day for ninety days and half a dummy pill, beside standard rehab. Arm function at day ninety is the main score, with brain scans of rewiring as a second check.

Catalog record

CREATORNicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13141164

Browse the full library · About the Tower of Babel